Min-je Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 02, 2025
Downregulation of TRIB3 enhances the sensitivity of lung cancer cells to amino acid deprivation by suppressing AKT activation.
Journal: American journal of cancer research
Published: February 13, 2024
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 27, 2023
The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest.
Journal: Frontiers in pharmacology
Published: September 22, 2017
Trifolin induces apoptosis via extrinsic and intrinsic pathways in the NCI-H460 human non-small cell lung-cancer cell line.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 13, 2016
H9 Inhibits Tumor Growth and Induces Apoptosis via Intrinsic and Extrinsic Signaling Pathway in Human Non-Small Cell Lung Cancer Xenografts.
Journal: Journal of microbiology and biotechnology
Published: February 03, 2015
H9 induces apoptosis via the intrinsic pathway in non-small-cell lung cancer A549 cells.
Journal: Journal of microbiology and biotechnology
Published: January 08, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026